One-Quarter of Adnexal Masses in Youth Are Malignant

Share this content:
One-Quarter of Adnexal Masses in Youth Are Malignant
One-Quarter of Adnexal Masses in Youth Are Malignant

MONDAY, Feb. 9, 2015 (HealthDay News) -- For children and adolescents with an adnexal mass, about 25 percent of masses are malignant, according to a study published online Feb. 4 in Obstetrics & Gynecology.

Ayke J. Hermans, M.D., from the Radboud University Medical Center in Nijmegen, Netherlands, and colleagues conducted a retrospective cohort study involving patients aged younger than 18 years who were diagnosed with or treated for an adnexal mass. The authors analyzed age, signs and symptoms, laboratory results, imaging data, type of surgery, and histologic diagnosis for 111 patients (mean age 10.2 ± 5.6 years).

The researchers found that in 25.2 percent of patients, ovarian masses were malignant. In 83.1 percent of benign masses and 100 percent of malignant masses, surgical therapy was applied. In 46.4 percent of benign masses, oophorectomy was performed. The only factor that significantly lowered the odds of oophorectomy in benign masses was the presence of a gynecologist (odds ratio, 0.14). The sensitivity and specificity of Papic et al's model were 40.91 and 100 percent, respectively.

"The malignancy rate among patients with adnexal masses in our cohort was one in four patients," the authors write. "The presence of a gynecologic surgeon protected against oophorectomy in benign cases."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »